在我主动提出帮助的所有从事新冠相关工作的公司和非营利组织中,几乎每一家都请求临床试验方面的支持——对于那些专注于开发新药、疫苗和诊断产品的公司来说,快速启动临床试验是他们最大的瓶颈之一。 Almost every company and non-profit working on COVID-19 that I offered to help asked for support with clinical trials—for companies focusing on developing novel drugs, vaccines, and diagnostics, rapidly spinning up trials is one of their biggest bottlenecks. ¶
科学仍然是走出新冠危机的唯一出路。大幅改进临床试验——它们通常旷日持久、耗资数千万乃至数亿美元——是让我们更快走出危机的最高杠杆方式之一。 Science remains the only way out of the COVID-19 crisis. Dramatically improving clinical trials, which are usually time-consuming and cost tens to hundreds of millions of dollars, is one of the highest-leverage ways to get out of it faster. ¶
本项目的目标,是与 TrialSpark 及 Mark Fishman 博士(Dr. Mark Fishman)合作,为新冠项目提供远优于现有任何方案的临床试验支持。 The goal of this project, in collaboration with TrialSpark and Dr. Mark Fishman, is to offer much better clinical trial support to COVID-19 projects than anything that currently exists. ¶
Covalence 计划的平台由 TrialSpark 提供技术支持,专门针对新冠试验进行了独特优化;这类试验最理想的开展场景是社区环境或患者家中,以减轻医院和医疗系统的负担。Covalence 计划有条件解决启动此类试验所涉及的运营和后勤挑战,并提供试验执行、符合 21 CFR Part 11 规范的远程数据采集、远程医疗、生物统计、居家样本采集套件以及试验方案撰写等支持。 Project Covalence’s platform, powered by TrialSpark, is uniquely optimized to support COVID-19 trials, which are ideally run in community settings or at the patient’s home to reduce the burden placed on hospitals and health systems. Project Covalence is well-positioned to tackle the operational and logistical challenges involved in launching such trials, and supports trial execution, 21 CFR Part 11 compliant remote data collection, telemedicine, biostatistics, sample kits for at-home specimen collection, and protocol writing. ¶
学术界和产业界的研究人员都可以利用这一共享基础设施快速启动自己的临床试验。为促进各项研究之间的协调,我们还将为平台型研究创建主方案(master protocols),以实现共享对照组和适应性试验设计。 Researchers across academia and industry can leverage this shared infrastructure to rapidly launch their clinical trials. To facilitate coordination between studies, we will also be creating master protocols for platform studies to enable shared control arms and adaptive trial designs. ¶
如果你有意参与,或有一项试验需要支持,请通过 ProjectCovalence@trialspark.com 与我们联系,或访问 www.projectcovalence.com (http://www.projectcovalence.com/)。 If you’re interested in getting involved or have a trial that needs support, please get in touch at ProjectCovalence@trialspark.com or visit www.projectcovalence.com (http://www.projectcovalence.com/). ¶